Merck Serono S.A. - Strategic SWOT Analysis Review

Merck Serono S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Merck Serono S.A., (Merck Serono) is the biopharmaceutical division of Merck KGaA. It discovers, develops, manufactures and commercializes prescription medicines of both chemical and biological origin in specialist indications with focus on the neurology, cancer, immuno-oncology and immunology. Merck Serono has a broad product portfolio, which is distributed across the world through a network of distributors. The division manages four research and development centers in the US, Germany, China and Japan. It has a global presence with operations in more than 150 countries and production facilities in four countries.

Merck Serono S.A. Key Recent Developments

Jan 09, 2014: Merck Serono Appoints Steven Hildemann as Global Chief Medical Officer
Nov 15, 2013: Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility
Nov 04, 2013: Merck Serono Grant for Growth Innovation Countdown for Accepting Proposals
Oct 10, 2013: Merck Serono Opens New Global Headquarters in Darmstadt
Oct 08, 2013: Merck releases new data on effectiveness of Cognigram

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.